This file is provided for reference purposes only. It was current when it was produced, but it is no longer maintained and may now be out of date. Persons with disabilities having difficulty accessing information may
contact us for assistance. For reliable, current information on this and other health topics, we recommend consulting the NIH Clinical Center at
http://www.cc.nih.gov/.
|
Dangerous
Liaisons: Drugs and Herbal Products
Dr. Aaron
Burstein, Pharmacokineticist
Clinical Pharmacokinetics Research Laboratory
Pharmacy Department, NIH Clinical Center Diseases
|
Tuesday,
Oct. 3, 2000 • 7 pm
Masur Auditorium•NIH Clinical Center
|
|
 |
Dr. Aaron H. Burstein received
his Bachelor of Science in pharmacy from the State University of New York at
Buffalo. In 1993, he earned his Doctor of Pharmacy degree there. He completed
his residency in pharmacy at the Moses H. Cone Memorial Hospital in Greensboro,
North Carolina. He did his postdoctoral training in clinical neuropharmacology
at the Dent Neurologic Institute in Buffalo.
Dr. Burstein served as an
Assistant Professor in the Department of Pharmacy Practice and Science at the
University of Maryland. In April, 1999, he joined NIH as a pharmacokineticist
with the Clinical Pharmacokinetics Research Laboratory in the Clinical Center's
Pharmacy Department. He is also a member of the Clinical Center's Alternative
Supplements Task Force.
His NIH responsibilities
include serving as a member of the Institutional Review Board for the National
Institute of Neurological Disorders and Stroke. He has authored or coauthored
over 40 publications, abstracts, book reviews, and book chapters. Dr. Burstein
has taught advanced pharmacy courses at the University of Maryland, where he
not only instructed students, but also served as a mentor in the University's
Clinical Sciences Fellowship and in the NIH Minority Research Apprenticeship
Program. In 1996, he received the American College of Clinical Pharmacy Wyeth-Ayerst
Laboratories Women's Healthcare Research Award. He holds membership in numerous
professional organizations, including the American Epilepsy Society, the American
Society for Clinical Pharmacology and Therapeutics, and the American College
of Clinical Pharmacy, in which he is a full member and has held various leadership
positions.
Dr. Burstein has presented
on drug therapy for seizure disorders and epilepsy at numerous conferences,
hospitals, and medical centers nationwide. Most recently, he spoke on herb-drug
interactions focusing on St. John's wort at Clinical Center Grand Rounds, held
at NIH this past June. In February, he addressed NIH's epilepsy interest group
conference on herb-antiepileptic drug interactions. His research interests focus
on the effects of medications and herbs on pathways of drug elimination from
the body. Recent research efforts have focused on drug interactions with herbal
products and prescription medications.
Medicine
for the Public home
The information on this page is archived and provided for reference purposes only.
